| Monocyte isolation techniques significantly impact the phenotype of both isolated monocytes and derived macrophages in vitro MC Nielsen, MN Andersen, HJ Møller Immunology 159 (1), 63-74, 2020 | 157 | 2020 |
| Characterization of circulating T-, NK-, and NKT cell subsets in patients with colorectal cancer: the peripheral blood immune cell profile D Krijgsman, NL de Vries, A Skovbo, MN Andersen, M Swets, ... Cancer Immunology, Immunotherapy 68, 1011-1024, 2019 | 150 | 2019 |
| A flow cytometric method for characterization of circulating cell-derived microparticles in plasma MH Nielsen, H Beck-Nielsen, MN Andersen, A Handberg Journal of extracellular vesicles 3 (1), 20795, 2014 | 149 | 2014 |
| Elimination of erroneous results in flow cytometry caused by antibody binding to Fc receptors on human monocytes and macrophages MN Andersen, SNH Al‐Karradi, TW Kragstrup, M Hokland Cytometry Part A 89 (11), 1001-1009, 2016 | 137 | 2016 |
| Monocyte/macrophage‐derived soluble CD 163: a novel biomarker in multiple myeloma MN Andersen, N Abildgaard, MB Maniecki, HJ Møller, NF Andersen European journal of haematology 93 (1), 41-47, 2014 | 77 | 2014 |
| STAT3 inhibition specifically in human monocytes and macrophages by CD163-targeted corosolic acid-containing liposomes MN Andersen, A Etzerodt, JH Graversen, LC Holthof, SK Moestrup, ... Cancer Immunology, Immunotherapy 68, 489-502, 2019 | 60 | 2019 |
| The novel biomarker of alternative macrophage activation, soluble mannose receptor (sMR/sCD206): Implications in multiple myeloma MN Andersen, NF Andersen, S Rødgaard-Hansen, M Hokland, ... Leukemia research 39 (9), 971-975, 2015 | 58 | 2015 |
| The macrophage-related biomarkers sCD163 and sCD206 are released by different shedding mechanisms MC Nielsen, MN Andersen, N Rittig, S Rødgaard-Hansen, H Grønbæk, ... Journal of leukocyte biology 106 (5), 1129-1138, 2019 | 57 | 2019 |
| Soluble ectodomain CD163 and extracellular vesicle-associated CD163 are two differently regulated forms of ‘soluble CD163’in plasma A Etzerodt, RMG Berg, RR Plovsing, MN Andersen, M Bebien, ... Scientific Reports 7 (1), 40286, 2017 | 51 | 2017 |
| Ultrasound-guided lumbar plexus block in volunteers; a randomized controlled trial JMC Strid, AR Sauter, K Ullensvang, MN Andersen, M Daugaard, ... BJA: British Journal of Anaesthesia 118 (3), 430-438, 2017 | 41 | 2017 |
| CD163 as a biomarker in colorectal cancer: the expression on circulating monocytes and tumor-associated macrophages, and the soluble form in the blood D Krijgsman, NL De Vries, MN Andersen, A Skovbo, RAEM Tollenaar, ... International journal of molecular sciences 21 (16), 5925, 2020 | 38 | 2020 |
| Increased interleukin (IL)-20 and IL-24 target osteoblasts and synovial monocytes in spondyloarthritis TW Kragstrup, MN Andersen, B Schiøttz-Christensen, AG Jurik, M Hvid, ... Clinical & Experimental Immunology 189 (3), 342-351, 2017 | 37 | 2017 |
| Increased PD-L1 expression in erlotinib-resistant NSCLC cells with MET gene amplification is reversed upon MET-TKI treatment C Demuth, MN Andersen, KR Jakobsen, AT Madsen, BS Sørensen Oncotarget 8 (40), 68221, 2017 | 36 | 2017 |
| Histone Deacetylase Inhibitor Romidepsin Inhibits De Novo HIV-1 Infections KL Jønsson, M Tolstrup, J Vad-Nielsen, K Kjær, A Laustsen, ... Antimicrobial Agents and Chemotherapy 59 (7), 3984-3994, 2015 | 31 | 2015 |
| Responses to cytokine inhibitors associated with cellular composition in models of immune‐mediated inflammatory arthritis MA Nielsen, S Lomholt, A Mellemkjær, MN Andersen, CD Buckley, ... ACR open rheumatology 2 (1), 3-10, 2020 | 27 | 2020 |
| Expression of NK cell receptor ligands in primary colorectal cancer tissue in relation to the phenotype of circulating NK-and NKT cells, and clinical outcome D Krijgsman, J Roelands, MN Andersen, CHLA Wieringa, ... Molecular Immunology 128, 205-218, 2020 | 21 | 2020 |
| Circulating extracellular vesicle‐associated CD163 and CD206 in multiple myeloma SL Kvorning, MC Nielsen, NF Andersen, M Hokland, MN Andersen, ... European Journal of Haematology 104 (5), 409-419, 2020 | 19 | 2020 |
| Serum galectin-1 in patients with multiple myeloma: Associations with survival, angiogenesis, and biomarkers of macrophage activation MN Andersen, M Ludvigsen, N Abildgaard, I Petruskevicius, R Hjortebjerg, ... OncoTargets and therapy, 1977-1982, 2017 | 19 | 2017 |
| Soluble macrophage mannose receptor (sCD206/sMR) as a biomarker in human immunodeficiency virus infection MN Andersen, BL Hønge, S Jespersen, C Medina, D da Silva Té, ... The Journal of infectious diseases 218 (8), 1291-1295, 2018 | 17 | 2018 |
| Preclinical evidence for an effective therapeutic activity of FL118, a novel survivin inhibitor, in patients with relapsed/refractory multiple myeloma LC Holthof, HJ van der Horst, SE van Hal-van Veen, RWJ Ruiter, F Li, ... Haematologica 105 (2), e80, 2020 | 16 | 2020 |
